Galectin Therapeutics (GALT) Common Equity (2010 - 2026)
Galectin Therapeutics' quarterly Common Equity came in at -$132.0 million in Q1 2026, down 15.77% year-on-year from -$156.7 million in Q1 2025, and down 3.16% quarter-over-quarter from -$127.9 million in Q4 2025.
Galectin Therapeutics has reported Common Equity for 17 years, with the latest figure at -$132.0 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 15.77% year-over-year to -$132.0 million; the trailing twelve-month figure through Mar 2026 stood at -$132.0 million (down 15.77% YoY), and the FY2025 full-year result was -$127.9 million, down 22.07% from the prior year.
- Common Equity for Q1 2026 stood at -$132.0 million, down from -$127.9 million in the prior quarter.
- The five-year high for Common Equity was -$7.9 million in Q1 2022, with the low at -$132.0 million in Q1 2026.
- Average Common Equity over 5 years is -$72.9 million, with a median of -$62.0 million recorded in 2023.
- Year-over-year, Common Equity tumbled 3898.1% in 2022 and changed 0.0% in 2024.
- Tracing GALT's Common Equity over 5 years: stood at -$33.9 million in 2022, then slumped by 82.69% to -$62.0 million in 2023, then sank by 69.12% to -$104.8 million in 2024, then dropped by 22.07% to -$127.9 million in 2025, then declined by 3.16% to -$132.0 million in 2026.
- The last three Common Equity figures came in at -$132.0 million (Q1 2026), -$127.9 million (Q4 2025), and -$125.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -131.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131.96 Mn |
| Dec 31, 2025 | -127.92 Mn |
| Sep 30, 2025 | -125.30 Mn |
| Jun 30, 2025 | -118.89 Mn |
| Mar 31, 2025 | -113.98 Mn |
| Dec 31, 2024 | -104.79 Mn |
| Sep 30, 2024 | -94.20 Mn |
| Jun 30, 2024 | -83.87 Mn |
| Mar 31, 2024 | -44.37 Mn |
| Dec 31, 2023 | -61.96 Mn |
| Sep 30, 2023 | -52.60 Mn |
| Jun 30, 2023 | -52.85 Mn |
| Mar 31, 2023 | -44.37 Mn |
| Dec 31, 2022 | -33.92 Mn |
| Sep 30, 2022 | -24.06 Mn |
| Jun 30, 2022 | -16.95 Mn |
| Mar 31, 2022 | -7.92 Mn |
| Dec 31, 2021 | 893,000.00 |
| Sep 30, 2021 | 7.53 Mn |
| Jun 30, 2021 | 15.39 Mn |
| Mar 31, 2021 | 16.51 Mn |
| Dec 31, 2020 | 22.47 Mn |
| Sep 30, 2020 | 29.82 Mn |
| Jun 30, 2020 | 35.29 Mn |
| Mar 31, 2020 | 41.03 Mn |
| Dec 31, 2019 | 43.87 Mn |
| Sep 30, 2019 | 47.76 Mn |
| Jun 30, 2019 | 49.90 Mn |
| Mar 31, 2019 | 5.12 Mn |
| Dec 31, 2018 | 5.18 Mn |
| Sep 30, 2018 | 7.25 Mn |
| Jun 30, 2018 | 8.05 Mn |
| Mar 31, 2018 | 925,000.00 |
| Dec 31, 2017 | -530,000.00 |
| Sep 30, 2017 | 947,000.00 |
| Jun 30, 2017 | 4.09 Mn |
| Mar 31, 2017 | 7.91 Mn |
| Dec 31, 2016 | 10.29 Mn |
| Sep 30, 2016 | 10.31 Mn |
| Jun 30, 2016 | 7.49 Mn |
| Mar 31, 2016 | 12.47 Mn |
| Dec 31, 2015 | 18.04 Mn |
| Sep 30, 2015 | 12.84 Mn |
| Jun 30, 2015 | 17.88 Mn |
| Mar 31, 2015 | 21.85 Mn |
| Dec 31, 2014 | 21.20 Mn |
| Sep 30, 2014 | 23.22 Mn |
| Jun 30, 2014 | 25.72 Mn |
| Mar 31, 2014 | 28.27 Mn |
| Dec 31, 2013 | 1.48 Mn |
| Sep 30, 2013 | 1.30 Mn |
| Jun 30, 2013 | -3.09 Mn |
| Mar 31, 2013 | -1.04 Mn |
| Dec 31, 2012 | 1.17 Mn |
| Sep 30, 2012 | 3.06 Mn |
| Jun 30, 2012 | 4.91 Mn |
| Mar 31, 2012 | 6.82 Mn |
| Dec 31, 2011 | -2.13 Mn |
| Sep 30, 2011 | 823,000.00 |
| Jun 30, 2011 | 915,000.00 |
| Dec 31, 2010 | -1.69 Mn |